Your browser doesn't support javascript.
loading
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.
Lu, Shun; Zhang, Wei; Wu, Lin; Wang, Wenxiang; Zhang, Peng; Fang, Wentao; Xing, Wenqun; Chen, Qixun; Yang, Lin; Mei, Jiandong; Tan, Lijie; Sun, Xiaohong; Xu, Shidong; Hu, Xiaohua; Yu, Guohua; Yu, Dongliang; Yang, Nong; Chen, Yuping; Shan, Jinlu; Xing, Ligang; Tian, Hui; Zhang, Xun; Zhou, Ming; Fang, Haohui; Wu, Guowu; Liu, Yunpeng; Ye, Minhua; Cao, Lejie; Jiang, Jie; Li, Xingya; Zhu, Liangming; Li, Danqing; Kang, Mingqiang; Zhong, Aihong; Chen, Keneng; Wu, Nan; Sun, Qian; Ma, Haitao; Cai, Kaican; Wang, Changli; Lin, Gen; Zhu, Kunshou; Zhang, Yu; Zhang, Xiaochun; Hu, Hong; Zhang, Wengang; Chen, Jun; Yang, Zhixiong; Hang, Xiaosheng; Hu, Jian.
Afiliação
  • Lu S; Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang W; First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Wang W; Second Department of Thoracic Surgery, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Zhang P; Shanghai Pulmonary Hospital, Tong Ji University, Shanghai, China.
  • Fang W; Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Xing W; Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Chen Q; Zhejiang Cancer Hospital, Hangzhou, China.
  • Yang L; Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, Shenzhen, China.
  • Mei J; West China Hospital, Sichuan University, Chengdu, China.
  • Tan L; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Sun X; Cancer Hospital affiliated with Xinjiang Medical University, Urumqi, China.
  • Xu S; Harbin Medical University Cancer Hospital, Harbin, China.
  • Hu X; Tumor Hospital affiliated with Guangxi Medical University, Nanning, China.
  • Yu G; Weifang People's Hospital, Weifang, China.
  • Yu D; Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yang N; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Chen Y; Cancer Hospital affiliated with Shantou University Medical College, Shantou, China.
  • Shan J; Daping Hospital, Army Medical University, Chongqing, China.
  • Xing L; Shandong Cancer Hospital and Institute, Jinan, China.
  • Tian H; Qilu Hospital affiliated with Shandong University, Jinan, China.
  • Zhang X; Tianjin Chest Hospital, Tianjin, China.
  • Zhou M; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
  • Fang H; Anhui Chest Hospital, Hefei, China.
  • Wu G; Meizhou People's Hospital (Huangtang Hospital), Meizhou, China.
  • Liu Y; First Hospital of China Medical University, Shenyang.
  • Ye M; Taizhou Hospital of Zhejiang Province, Taizhou, China.
  • Cao L; Anhui Provincial Hospital, Hefei, China.
  • Jiang J; First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Li X; First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhu L; Central Hospital affiliated with Shandong First Medical University, Jinan, China.
  • Li D; Peking Union Medical College Hospital, Beijing, China.
  • Kang M; Fujian Medical University Union Hospital, Fuzhou, China.
  • Zhong A; Fuzhou Tuberculosis Control Hospital of Fujian, Fuzhou Pulmonary Hospital of Fujian, Fuzhou, China.
  • Chen K; Beijing Cancer Hospital, Beijing, China.
  • Wu N; Beijing Cancer Hospital, Beijing, China.
  • Sun Q; Henan Provincial Chest Hospital, Zhengzhou, China.
  • Ma H; First Affiliated Hospital of Soochow University, Suzhou, China.
  • Cai K; Nanfang Hospital Southern Medical University, Guangzhou, China.
  • Wang C; Tianjin Cancer Hospital, Tianjin, China.
  • Lin G; Fujian Cancer Hospital, Fuzhou, China.
  • Zhu K; Fujian Cancer Hospital, Fuzhou, China.
  • Zhang Y; Nanjing Chest Hospital Medical School of Southern University, Nanjing, China.
  • Zhang X; Affiliated Hospital of Medical College Qingdao University, Qingdao, China.
  • Hu H; Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhang W; Tonghua Central Hospital, Tonghua, China.
  • Chen J; Tianjin Medical University General Hospital, Tianjin, China.
  • Yang Z; Affiliated Hospital of Guangdong Medical University, Guangzhou, China.
  • Hang X; Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Hu J; First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
JAMA ; 331(3): 201-211, 2024 01 16.
Article em En | MEDLINE | ID: mdl-38227033
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Platina / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Platina / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China